Type 1 Papillary Renal Cell Carcinoma Completed Phase 1 / 2 Trials for Fludarabine (DB01073)

Also known as: Papillary Renal Cell Carcinoma Type 1

IndicationStatusPhase
DBCOND0029157 (Type 1 Papillary Renal Cell Carcinoma)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00078858Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell TransplantTreatment
NCT00027820Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney CancerTreatment